FDA grants clearance for Eyas Medical Imaging’s neonatal MRI system
February 6, 2026
Eyas Medical Imaging is currently scaling up operations with plans to commercialise the system in the US later this year.
Eyas Medical Imaging is currently scaling up operations with plans to commercialise the system in the US later this year.
More than 2,000 known CFTR mutations have been identified worldwide. The type of mutation a patient carries can alter everything from how severe their symptoms are to what drugs will work for them.
A study led by researchers at UT Southwestern, published in the Journal of Clinical Investigation, suggests that a protein secreted by immune cells within these tumors causes them to grow even in the absence of estrogen.
Researchers at Washington University School of Medicine in St. Louis have developed a new tool to detect reconstruction-related infections early, before they cause symptoms.
With this FDA approval, Hologic now offers three guideline-recommended methods: Pap testing, HPV primary testing, and co-testing.
AVENTURA, Fla., Feb. 4, 2026 /PRNewswire/ — Nuvo Intl Group Inc. today announced that pregnant moms can lease the FDA-cleared INVU wearable solution , a cloud-based pregnancy monitoring platform designed for use at home or at work, directly through their physician or healthcare provider.
TSC Life announced that it received FDA clearance for its Fluido Compact fluid warming system for pediatric use.
Testing menstrual blood for human papillomavirus (HPV) could be a “robust alternative or replacement” for current cervical cancer screening by a clinician.
For people who are at high risk of developing breast cancer, frequent screenings with ultrasound can help detect tumors early.
Northwestern University researchers have developed the first device that can continuously track a fetus’s vital signs while still in the uterus.